Radiat Res 2008, 170 (1) : 41–48.CrossRefPubMed 14. Shimokuni
T, Tanimoto K, Hiyama K, Otani K, Ohtaki M, Hihara J, Yoshida K, Noguchi T, Kawahara K, Natsugoe S, et al.: Chemosensitivity Selleckchem Saracatinib prediction in esophageal squamous cell carcinoma: novel marker genes and efficacy-prediction formulae using their expression data. Int J Oncol 2006, 28 (5) : 1153–1162.PubMed 15. Song X, Liu X, Chi W, Liu Y, Wei L, Wang X, Yu J: Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung https://www.selleckchem.com/products/prn1371.html cancer is inhibited by silencing of HIF-1alpha gene. Cancer Chemother Pharmacol 2006, 58 (6) : 776–784.CrossRefPubMed 16. Suit H: The Gray Lecture 2001: coming technical advances in radiation oncology. Int J Radiat Oncol Biol Phys 2002, 53 (4) : 798–809.CrossRefPubMed 17. Ogawa K, Utsunomiya T, Mimori K, Tanaka F, Haraguchi N, Inoue H, Murayama S, Mori M: Differential gene expression selleck inhibitor profiles of radioresistant pancreatic cancer
cell lines established by fractionated irradiation. Int J Oncol 2006, 28 (3) : 705–713.PubMed 18. Gupta S, Ahmed MM: A global perspective of radiation-induced signal transduction pathways in cancer therapeutics. Indian J Exp Biol 2004, 42 (12) : 1153–1176.PubMed 19. Ahmed KM, Dong S, Fan M, Li JJ: Nuclear factor-kappaB p65 inhibits mitogen-activated protein kinase signaling pathway in radioresistant breast cancer cells. Mol Cancer Res 2006, 4 (12) : 945–955.CrossRefPubMed 20. Ryu JS, Um JH, Kang CD, Bae JH, Kim DU, Lee YJ, Kim DW, Chung BS, Kim SH: Fractionated irradiation leads to restoration of drug sensitivity in MDR cells that correlates with down-regulation of P-gp and DNA-dependent protein kinase activity. Radiat Res 2004, 162 (5) : 527–535.CrossRefPubMed 21. Hill BT, Moran E, Etievant C, Perrin D, Masterson A, Larkin A, Whelan RD: Low-dose twice-daily fractionated X-irradiation of ovarian tumor
cells in vitro generates drug-resistant cells overexpressing two multidrug resistance-associated proteins, P-glycoprotein and MRP1. Anticancer Drugs 2000, 11 (3) : 193–200.CrossRefPubMed 22. Nielsen Mannose-binding protein-associated serine protease D, Maare C, Eriksen J, Litman T, Skovsgaard T: Expression of P-glycoprotein and multidrug resistance associated protein in Ehrlich ascites tumor cells after fractionated irradiation. Int J Radiat Oncol Biol Phys 2001, 51 (4) : 1050–1057.CrossRefPubMed 23. Martin LP, Hamilton TC, Schilder RJ: Platinum resistance: the role of DNA repair pathways. Clin Cancer Res 2008, 14 (5) : 1291–1295.CrossRefPubMed 24. Borst P, Rottenberg S, Jonkers J: How do real tumors become resistant to cisplatin? Cell Cycle 2008, 7 (10) : 1353–1359.PubMed 25. Watanabe Y, Koi M, Hemmi H, Hoshai H, Noda K: A change in microsatellite instability caused by cisplatin-based chemotherapy of ovarian cancer. Br J Cancer 2001, 85 (7) : 1064–1069.CrossRefPubMed 26.